Decreased response to the mRNA anti-SARS-CoV-2 vaccine in hepatitis B vaccine non-responders and frail patients treated with peritoneal dialysis

Nephrol Dial Transplant. 2022 May 25;37(6):1188-1190. doi: 10.1093/ndt/gfac031.

Authors

Michael Kolland¹, Regina Riedl², Bernhard Bachler¹, Werner Ribitsch¹, Tobias Niedrist³, Anna-Maria Meissl¹, Alexander R Rosenkranz¹, Alexander H Kirsch¹

Affiliations

¹ Department of Internal Medicine, Division of Nephrology, Medical University of Graz, Graz, Austria.
² Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
³ Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.

No abstract available

Publication types

Letter

MeSH terms

Aged
Antibodies, Viral
COVID-19 Vaccines / therapeutic use
COVID-19* / prevention & control
Frail Elderly
Hepatitis B Vaccines
Humans
Peritoneal Dialysis*
RNA, Messenger
Renal Dialysis

Substances

Antibodies, Viral
COVID-19 Vaccines
Hepatitis B Vaccines
RNA, Messenger